AU5051693A - Method and composition for treating inflammatory bowel disorders - Google Patents

Method and composition for treating inflammatory bowel disorders

Info

Publication number
AU5051693A
AU5051693A AU50516/93A AU5051693A AU5051693A AU 5051693 A AU5051693 A AU 5051693A AU 50516/93 A AU50516/93 A AU 50516/93A AU 5051693 A AU5051693 A AU 5051693A AU 5051693 A AU5051693 A AU 5051693A
Authority
AU
Australia
Prior art keywords
inflammatory bowel
bowel disorders
composition
treating inflammatory
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU50516/93A
Other versions
AU664492B2 (en
Inventor
Richard I. Breuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RICHARD J BREUER
Original Assignee
RICHARD J BREUER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RICHARD J BREUER filed Critical RICHARD J BREUER
Publication of AU5051693A publication Critical patent/AU5051693A/en
Assigned to BREUER, RICHARD I. reassignment BREUER, RICHARD I. Amend patent request/document other than specification (104) Assignors: Breuer, Richard J.
Application granted granted Critical
Publication of AU664492B2 publication Critical patent/AU664492B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A method for the treatment of inflammatory bowel disorders, together with a pharmaceutical composition comprising short chain fatty acids that is useful therein, is described in this invention. The administration of short chain fatty acids of about 2 to about 6 carbon-length to patients afflicated with inflammatory bowel disorders is shown to effectively alleviate the symptoms of the treated disorder.
AU50516/93A 1989-11-16 1993-11-08 Method and composition for treating inflammatory bowel disorders Ceased AU664492B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/438,297 US5039703A (en) 1989-11-16 1989-11-16 Method for treating inflammatory bowel disorders
US438297 1989-11-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU66817/90A Division AU6681790A (en) 1989-11-16 1990-11-21 Method and composition for treating inflammatory bowel disorders

Publications (2)

Publication Number Publication Date
AU5051693A true AU5051693A (en) 1994-01-13
AU664492B2 AU664492B2 (en) 1995-11-16

Family

ID=23740078

Family Applications (2)

Application Number Title Priority Date Filing Date
AU66817/90A Abandoned AU6681790A (en) 1989-11-16 1990-11-21 Method and composition for treating inflammatory bowel disorders
AU50516/93A Ceased AU664492B2 (en) 1989-11-16 1993-11-08 Method and composition for treating inflammatory bowel disorders

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU66817/90A Abandoned AU6681790A (en) 1989-11-16 1990-11-21 Method and composition for treating inflammatory bowel disorders

Country Status (11)

Country Link
US (1) US5039703A (en)
EP (1) EP0502925B1 (en)
AT (1) ATE143261T1 (en)
AU (2) AU6681790A (en)
CA (1) CA2071215C (en)
DE (1) DE69028712T2 (en)
DK (1) DK0502925T3 (en)
ES (1) ES2093695T3 (en)
GR (1) GR3021760T3 (en)
IL (1) IL96365A (en)
WO (1) WO1991007176A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013801A1 (en) * 1993-11-17 1995-05-26 Commonwealth Scientific And Industrial Research Organisation Fatty acid delivery system
US6245326B1 (en) 1997-06-30 2001-06-12 Sigma Pharmaceuticals Pty. Ltd. Health supplement

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (en) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TALASSEMIA CONTAINING BUTYRRIC ACID DERIVATIVES AND IN PARTICULAR ISOBUTYRAMIDE
CA2174737C (en) * 1993-10-29 2008-04-22 Douglas V. Faller Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
WO1999040883A2 (en) * 1998-02-11 1999-08-19 Faller Douglas V Compositions and methods for the treatment of cystic fibrosis
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
GB0127916D0 (en) * 2001-11-21 2002-01-16 Rowett Res Inst Method
ITMI20040187A1 (en) * 2004-02-06 2004-05-06 Cosmo Spa PHARMACEUTICAL OR DIETETIC COMPOSITIONS BASED ON SHORT CHAIN FATTY ACIDS AND COMPLEX SUGARS FOR INTESTINAL DYSFUNCTIONS
US20070071779A1 (en) * 2005-09-26 2007-03-29 Leggit Ingenuity, Llc Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
DK2349250T3 (en) * 2008-10-31 2017-07-03 Lipid Pharmaceuticals Ehf Fatty acids for use as a medicament
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (en) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc Methods and low dose regimens for treating red blood cell disorders
JP4620169B1 (en) * 2010-01-28 2011-01-26 株式会社三和化学研究所 A preventive or therapeutic agent for Crohn's disease comprising an organic acid polymer as an active ingredient
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
EP2971127B1 (en) 2013-03-14 2018-02-28 University Of Ottawa Methods for the diagnosis and treatment of inflammatory bowel disease
WO2016049772A1 (en) 2014-10-03 2016-04-07 University Of Ottawa Markers for inflammatory bowel disease
US11291693B2 (en) 2015-06-25 2022-04-05 Synlogic Operating Company, Inc. Bacteria engineered to treat metabolic diseases
EP3496708A4 (en) * 2016-08-10 2020-04-01 Monash University Metabolites for treatment and prevention of autoimmune disease
JP7136807B2 (en) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ Polymeric materials for the intestinal delivery of short-chain fatty acids for therapeutic applications in human health and disease
AU2020283590A1 (en) 2019-05-31 2022-01-20 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995013801A1 (en) * 1993-11-17 1995-05-26 Commonwealth Scientific And Industrial Research Organisation Fatty acid delivery system
US5840860A (en) * 1993-11-17 1998-11-24 Commonwealth Scientific And Industrial Research Organization Fatty acid delivery system comprising a hydrolyzable bond
US6245326B1 (en) 1997-06-30 2001-06-12 Sigma Pharmaceuticals Pty. Ltd. Health supplement

Also Published As

Publication number Publication date
US5039703A (en) 1991-08-13
CA2071215A1 (en) 1991-05-17
DK0502925T3 (en) 1996-12-23
GR3021760T3 (en) 1997-02-28
DE69028712T2 (en) 1997-03-20
WO1991007176A1 (en) 1991-05-30
EP0502925B1 (en) 1996-09-25
IL96365A0 (en) 1991-08-16
AU664492B2 (en) 1995-11-16
ATE143261T1 (en) 1996-10-15
EP0502925A1 (en) 1992-09-16
ES2093695T3 (en) 1997-01-01
CA2071215C (en) 1997-02-04
EP0502925A4 (en) 1992-12-16
AU6681790A (en) 1991-05-23
IL96365A (en) 1995-06-29
DE69028712D1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
AU6681790A (en) Method and composition for treating inflammatory bowel disorders
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
DE3268075D1 (en) Preparation for treating outer skin wounds and process for manufacturing said preparation
HUT65754A (en) Process for production of preparations containing complement inhibitors for treatment of inflammatory intestinal-and dermal-diseases
AU6909091A (en) Neurologic agents for nasal administration to the brain
DE3889536D1 (en) TREATING CANCER WITH SOMATOSTATIN AND WITH ANALOGS OF IT.
ATE43242T1 (en) PHARMACEUTICAL OR DIETETIC COMPOSITION WITH HIGH ANTITHROMBOTIC AND ANTIARTERIOSCLEROTIC ACTION.
PT880350E (en) MULTIPLE SCLEROSIS TREATMENT
DE69312579D1 (en) Medicines to treat vulvar dystrophy or vaginal dryness
BR9500436A (en) Products use of a g-csf use of a tnf protein ligand process for the treatment and / or prevention of septic shock
DE69426471D1 (en) Use of sulodexide and medicines containing it to treat diabetic nephropathy
GB2232593B (en) Process for improving the therapeutic efficacy of fat-soluble corticosteriods and composition for carrying out this process
DE69005062D1 (en) Fatty acids for the treatment and prevention of skin damage through radiotherapy.
HU891056D0 (en) Process for treating the diseases of the gullet and the stomach-intestine system
AU1595088A (en) Kernel oils and disease treatment
GR3032779T3 (en) A method for using lipoprotein associated coagulation inhibitor to treat sepsis.
PT76247B (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
GR3006674T3 (en)
GR3007995T3 (en)
FR2600256B1 (en) DRUG AND DRUG COMPOSITION FOR THE TREATMENT OF TUMORS AND FOR THE TREATMENT OF VIRUS-INFECTIOUS DISEASES
MX9203208A (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF DIGESTIVE DISORDERS.
HU9200400D0 (en) Cinurenic acid derivatives, process for producing them and pharmaceutical compositions containing them
EP0407788A3 (en) Use of retinoids for the treatment and prophylaxis of immune related diseases
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
GB8928609D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired